Foetal Drug Exposure & The Placenta Flashcards
what is placenta
- placenta = organ that connects maternal and foetal circulation
- semi-permeable barrier
> allows exchange of nutrients, gases, other compounds
> allows elimination of wastes
3 main mechanisms by which medications cross the placenta
Placental Drug Transfer
- passive diffusion
- facilitated diffusion
- active transport
list factors that influence passive diffusion
(in brackets what is more likely to pass)
- molecular weight (lower)
- lipophilicity (more lipophilic)
- protein binding (unbound)
- ionisation (non-ionised)
- concentration gradient
- placental thickness (thinner)
- placental blood flow
all drugs in circulation have an equilibrium of
which will cross the placenta
- protein bound and free drug
- ionised and non-ionised drug
only unbound / free crosses placenta
non-ionised
phenomenon can occur for both
why cant highly ionised drugs cross placental barrier
too hydrophilic
placental changes during gestation include increases in …. with the increasing _______ _______ of foetus
which have what affect on passive diffusion
increase in
- blood flow
- surface area
- placental permeability
which increase passive diffusion
with the increasing nutritional requirements of foetus
what results in transport of the drug from maternal to foetal circulation and vice versa; into and out of foetal circulation (can pump drug out of foetal circulation and back into maternal circulation)
- facilitated diffusion
- active transport
facilitated diffusion and active transport tends to occur with drugs that have structural similarities to _____ compounds
drug structure - endogenous compounds
what does facilitated diffusion require (2)
- carrier substance - saturable
- concentration gradient
what does active transport require (2)
- active transport proteins
- energy-dependent (=> don’t need gradient)
what is active transport not dependent on
- concentration gradient (diffusions both are)
- electrochemical gradient
list 3 active transport proteins
- P-glycoprotein
- multi-drug resistance protein
- breast cancer resistance protein
what can presence of enzymes on placenta surface alter
drug exposure (drug levels in body)
Placental Metabolism involves the
expression of metabolising enzymes (cytochrome P450) on surface of placenta
when could placental metabolism be of clinical significance
- when treatment relies on foetal exposure to a drug
- since placental metabolism alters drug exposure and foetal exposure